FACE — Facephi Biometria SA Income Statement
0.000.00%
- €56.86m
- €61.76m
- €35.98m
Annual income statement for Facephi Biometria SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 13.2 | 22.3 | 25.2 | 28.9 | 36 |
| Cost of Revenue | |||||
| Gross Profit | 13.5 | 22.9 | 13.7 | 14.7 | 24.4 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13.6 | 20.5 | 30.5 | 35.5 | 34.6 |
| Operating Profit | -0.4 | 1.75 | -5.38 | -6.67 | 1.43 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.853 | 1.03 | -7.06 | -7.33 | 0.278 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.554 | 1.11 | -4.31 | -8.88 | 0.369 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.554 | 1.11 | -4.31 | -8.88 | 0.369 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.554 | 1.11 | -4.31 | -8.88 | 0.369 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.046 | 0.064 | -0.204 | -0.352 | 0.014 |
| Dividends per Share |